StreetAlpha.app
Home › Stocks › BRTX

BioRestorative Therapies, Inc. (BRTX)

$1.05
▼ −19.92%
LAST CLOSE · NOV 20

BioRestorative Therapies develops adult stem cell treatments for spine and metabolic conditions and sells a cosmetic skin serum. It last closed at $1.05 on Nov 20, down 19.92% on the day. For the quarter ended Mar 2026, BRTX reported EPS of -$0.12 on revenue of $23,170, with revenue down 7.3% from a year ago. Over its last 6 reports the stock moved an average of 3.5% the session after earnings.

AI Auto Pilots
Is BRTX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold BRTX.

Key Stats

Last 12 months
Results
Revenue
$358K
−8.5% vs a year ago
Net income
−$11.1M
−3089.6% margin
EPS (diluted)
−$1.06
Gross margin
92.1%
$330K gross profit
Valuation
Market cap
$26.7M
25.5M shares
P/E
–
No P/E while losing money
Price to sales
74.7
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$3.1M
At Mar 31
Shareholder equity
$3.0M
Shares outstanding
25.5M
At May 14
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $46K$46KFY2021FY2022: $120K$120KFY2022FY2023: $146K$146KFY2023FY2024: $401K$401KFY2024FY2025: $360K$360KFY2025

From BRTX's SEC filings, latest 10-Q for the period ending Mar 31, 2026 (filed May 14). Last 12 months adds up the four latest quarters.

Last report
Nov 12
2025 · next date not set yet
Reported EPS
-$0.12
Quarter ended Mar 2026
Year ago EPS
-$0.64
Same quarter last year
Revenue
$23,170
−7.3% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Jun 2024: -$0.50Jun '24Sep 2024: -$0.13Sep '24Dec 2024: -$0.20Dec '24Mar 2025: -$0.64Mar '25Jun 2025: -$0.30Jun '25Sep 2025: -$0.33Sep '25Dec 2025: -$0.32Dec '25Mar 2026: -$0.12Mar '26Latest -$0.12
Revenue by quarter
Jun 2024: $89,100Jun '24Sep 2024: $233,600Sep '24Dec 2024: $43,300Dec '24Mar 2025: $25,000Mar '25Jun 2025: $303,300Jun '25Sep 2025: $11,800Sep '25Dec 2025: $19,600Dec '25Mar 2026: $23,170Mar '26Latest $23,170
How BRTX moved after its last 6 reports
Average move the session after a report ±3.5%
Nov 12, 2025After the close−9.4%
Aug 12, 2025After the close+2.0%
May 14, 2025After the close−2.3%
Mar 27, 2025After the close−1.1%
Nov 13, 2024After the close−1.9%
Aug 6, 2024After the close−4.3%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on BRTXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Technical Analysis

BRTX · as of the Nov 20 close · updated each morning
Downtrend, oversold

The stock is 38% below its 20 day and 77% below its 50 day average. It is 350% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 24), oversold. The nearest support is the 52 week low at $1.04, and the nearest resistance the Pivot at $1.15.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityNormal, 14.6%/day
Key levels
$28.2052 week high+2585.7%
$4.72200 day average+349.5%
$3.40100 day average+223.8%
$1.8550 day average+76.2%
$1.62Swing high (Nov 5)+54.3%
$1.4520 day average+38.1%
$1.26Pivot R1+20.0%
$1.15Pivot+9.5%
$1.05Last close
$1.0452 week low−1.0%
$0.94Pivot S1−10.5%
Indicators
RSI (14)24.01Oversold below 30Oversold
MACD-0.18Below its signal lineBearish
Stochastic3.3Near the bottom of its rangeOversold
ADX (14)35.6Trending down
Williams %R-98.5Oversold below −80, overbought above −20Oversold
CCI (20)-270.1Oversold below −100, overbought above 100Oversold
Rate of change−31.0%Change over 10 sessionsBearish
ATR (14)$0.15Typical daily range, 14.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for BRTX

What happened before

See how BRTX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow BRTX usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How BRTX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for BRTXHow many large options trades hit BRTX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

BRTX Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bearish
Strongly bearishNeutralStrongly bullish
  • ▼14 buying vs 21 selling
  • ▼Held by funds -10.1 pts
  • ▼Funds holding -7
  • ▼Superinvestors: 0 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding1421−33.3%
In funds' top 1000–
Held by funds0.3%10.5%−10.1 pts
New / increased14 / 010 / 3+7.7%
Reduced / sold out0 / 212 / 0+950.0%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See BRTX institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BRTX is in one of them and how their past BRTX trades turned out.

BRTX in the AI portfolios
Loading…

BRTX News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered BRTX in an article yet. Here's the latest on the wider market.

BRTX in the news

About BioRestorative Therapies

BioRestorative Therapies develops therapeutic products that use cell and tissue methods, mainly adult stem cells. Its lead candidate is made from a patient's own bone marrow stem cells and is being studied for chronic lower back pain caused by degenerative disc disease and for neck pain, with the aim of offering an option for patients who may otherwise face surgery. The company is also developing metabolic treatments based on stem cells derived from fat, aimed at conditions such as obesity and type 2 diabetes. It sells a skin serum to consumers for fine lines and wrinkles and is based in Melville, New York.

Headquarters
Melville, NY